Doctors test direct brain injection to fight rare neurological disease
Disease control
Not yet recruiting
This is an early-stage study to see if a single injection of new brain cells (NouvNeu001) is safe and might help control symptoms of Multiple System Atrophy, a rare and serious neurological disease. It will involve 9 patients who are still able to walk with minimal assistance. Re…
Phase: PHASE1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC